Adverse Cutaneous Reactions to Erlotinib | Actas Dermo-Sifiliográficas

Statistics

Original articles

Adverse Cutaneous Reactions to Erlotinib

Efectos Cutáneos Adversos Causados Por Erlotinib

G. Pitarcha,

Corresponding author

gerardpitarch@hotmail.com

Correspondence: Servicio de Dermatología, Hospital General de Castelló, Avda. Benicàssim s/n, 12004 Castelló de la Plana, Spain.

, J. Gardeb, A. Torrijosa, A. Juárezb, M.I. Febrera, C. Campsb

a Servicio de Dermatología, Consorci Hospital General Universitari de València, Valencia, Spain

b Servicio de Oncología Médica, Consorci Hospital General Universitari de València, Valencia, Spain

Read

8079

Times
was read the article

3548

Total PDF

4531

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/S1578-2190(08)70194-X

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	22	13	35
2025 5	145	36	181
2025 4	127	29	156
2025 3	161	35	196
2025 2	137	56	193
2025 1	141	47	188
2024 12	123	35	158
2024 11	111	54	165
2024 10	98	51	149
2024 9	106	47	153
2024 8	136	93	229
2024 7	72	90	162
2024 6	71	80	151
2024 5	87	44	131
2024 4	90	40	130
2024 3	54	44	98
2024 2	57	36	93
2024 1	67	60	127
2023 12	63	46	109
2023 11	52	35	87
2023 10	40	32	72
2023 9	35	31	66
2023 8	25	25	50
2023 7	28	42	70
2023 6	51	25	76
2023 5	34	21	55
2023 4	24	17	41
2023 3	24	23	47
2023 2	24	16	40
2023 1	25	19	44
2022 12	24	36	60
2022 11	11	26	37
2022 10	22	27	49
2022 9	11	29	40
2022 8	16	33	49
2022 7	15	29	44
2022 6	14	24	38
2022 5	30	48	78
2022 4	30	34	64
2022 3	38	56	94
2022 2	15	23	38
2022 1	19	41	60
2021 12	22	34	56
2021 11	20	38	58
2021 10	29	45	74
2021 9	38	43	81
2021 8	17	21	38
2021 7	14	35	49
2021 6	27	23	50
2021 5	21	30	51
2021 4	53	27	80
2021 3	32	18	50
2021 2	29	22	51
2021 1	31	19	50
2020 12	19	13	32
2020 11	18	18	36
2020 10	13	5	18
2020 9	31	19	50
2020 8	19	19	38
2020 7	17	4	21
2020 6	16	22	38
2020 5	30	20	50
2020 4	20	20	40
2020 3	22	24	46
2020 2	2	8	10
2020 1	0	15	15
2019 12	0	14	14
2019 11	0	13	13
2019 10	0	7	7
2019 9	0	12	12
2019 8	0	8	8
2019 7	0	32	32
2019 6	0	18	18
2019 5	1	83	84
2019 4	0	53	53
2019 3	0	11	11
2019 2	0	6	6
2019 1	0	8	8
2018 12	0	5	5
2018 11	0	3	3
2018 10	0	1	1
2018 9	0	3	3
2018 8	0	9	9
2018 7	0	8	8
2018 6	0	2	2
2018 5	0	10	10
2018 4	0	12	12
2018 3	1	7	8
2018 2	15	9	24
2018 1	13	21	34
2017 12	12	12	24
2017 11	12	14	26
2017 10	16	12	28
2017 9	8	12	20
2017 8	16	17	33
2017 7	24	19	43
2017 6	17	15	32
2017 5	17	17	34
2017 4	13	28	41
2017 3	16	27	43
2017 2	19	20	39
2017 1	19	26	45
2016 12	38	24	62
2016 11	44	13	57
2016 10	32	15	47
2016 9	36	15	51
2016 8	38	25	63
2016 7	41	12	53
2016 6	9	9	18
2016 5	8	6	14
2016 4	7	15	22
2016 3	5	13	18
2016 2	11	12	23
2016 1	9	15	24
2015 12	8	8	16
2015 11	11	12	23
2015 10	12	15	27
2015 9	7	18	25
2015 8	10	7	17
2015 7	22	13	35
2015 6	32	8	40
2015 5	77	12	89
2015 4	47	5	52
2015 3	32	10	42
2015 2	10	11	21
2015 1	18	9	27
2014 12	23	5	28
2014 11	23	10	33
2014 10	35	7	42
2014 9	21	14	35
2014 8	33	19	52
2014 7	40	19	59
2014 6	47	9	56
2014 5	41	17	58
2014 4	28	7	35
2014 3	40	20	60
2014 2	31	26	57
2014 1	33	17	50
2013 12	36	25	61
2013 11	27	23	50
2013 10	29	25	54
2013 9	33	26	59
2013 8	30	38	68
2013 7	40	43	83
2013 6	27	30	57
2013 5	22	36	58
2013 4	19	36	55
2013 3	28	29	57
2013 2	36	15	51
2013 1	11	6	17

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter